Jan 13 (Reuters) - Salarius Pharmaceuticals Inc SLRX.O:
SALARIUS PHARMACEUTICALS AND DECOY THERAPEUTICS ANNOUNCE DEFINITIVE MERGER AGREEMENT
SALARIUS PHARMACEUTICALS INC - NEWLY FORMED COMPANY TO BE NAMED DECOY THERAPEUTICS
SALARIUS PHARMACEUTICALS INC - COMBINED COMPANY TO BE LED BY DECOY'S CO-FOUNDERS
SALARIUS PHARMACEUTICALS INC - NEW BOARD TO INCLUDE RICK PIERCE, BARBARA HIBNER, AND THREE INDEPENDENT DIRECTORS
SALARIUS PHARMACEUTICALS INC - DECOY INVESTORS TO OWN 86% OF MERGED COMPANY, SALARIUS STOCKHOLDERS 14%
Source text: ID:nGNX5562lK
Further company coverage: SLRX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.